CVS Health executive receives stock awards, pays taxes

CVS Health executive Prem S. Shah, EVP and Group President, reported equity compensation and related tax withholding transactions.

Rhea-AI Filing Summary

CVS Health executive Prem S. Shah, EVP and Group President, reported equity compensation and related tax withholding transactions. On March 31, 2026, he received a grant of 161,676 stock options with a $71.82 exercise price, exercisable in three equal annual installments beginning March 31, 2027 and expiring on March 31, 2036. He also received 25,062 shares of restricted common stock, awarded as restricted stock units under the company’s 2017 Incentive Compensation Plan, with restrictions lapsing in three equal installments starting March 31, 2027. On April 1, 2026, 1,484 common shares were surrendered at $72.49 per share to cover withholding taxes due upon vesting and settlement of restricted stock units, rather than sold in the open market. Following these transactions, Shah directly holds 64,356.0985 common shares.

Insider Trade Summary

3 transactions reported

Mixed 3 txns

Insider Shah Prem S

Role EVP and Group President

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock	1,484	$72.49	$108K
Grant/Award	Stock Option	161,676	$71.82	$11.61M
Grant/Award	Common Stock (Restricted)	25,062	$71.82	$1.80M

Holdings After Transaction: Stock Option — 161,676 contracts (Direct); Common Stock (Restricted) — 62,852 shares (Direct); Common Stock — 64,356.0985 shares (Direct)

Footnotes (3)

1. F1. Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in three equal installments, commencing 3/31/2027.
2. F2. Surrender of shares in payment of withholding taxes due upon the vesting and settlement of restricted stock units.
3. F3. Option becomes exercisable in three equal annual installments, commencing 3/31/2027.

Key Figures

Stock option grant: 161,676 options at $71.82 Restricted stock grant: 25,062 restricted shares Tax-withholding shares: 1,484 shares at $72.49 +1 more

4 metrics

Stock option grant 161,676 options at $71.82 Granted March 31, 2026; exercisable in three installments from March 31, 2027; expires March 31, 2036

Restricted stock grant 25,062 restricted shares Awarded March 31, 2026 as RSUs under 2017 Incentive Compensation Plan; restrictions lapse in three installments from March 31, 2027

Tax-withholding shares 1,484 shares at $72.49 Surrendered April 1, 2026 to pay withholding taxes on RSU vesting and settlement

Common shares held 64,356.0985 shares Direct CVS common stock holdings after reported transactions

Key Terms

restricted stock units, 2017 Incentive Compensation Plan, withholding taxes, stock option, +1 more

5 terms

restricted stock units financial

"Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

2017 Incentive Compensation Plan financial

"Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan."

withholding taxes financial

"Surrender of shares in payment of withholding taxes due upon the vesting and settlement of restricted stock units."

Withholding taxes are amounts a payer or government takes out of payments — such as wages, interest, or dividends — before the recipient gets the money, functioning like a cashier keeping part of a bill to pay taxes on your behalf. For investors this matters because it reduces the cash they actually receive, affects net returns and yield calculations, and may require additional paperwork or treaty claims to recover or offset the withheld amount against final tax bills.

stock option financial

"Option becomes exercisable in three equal annual installments, commencing 3/31/2027."

A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.

exercisable financial

"Option becomes exercisable in three equal annual installments, commencing 3/31/2027."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What equity awards did CVS (CVS) executive Prem S. Shah receive?

Prem S. Shah received a grant of 161,676 stock options at a $71.82 exercise price and 25,062 restricted common shares. The restricted shares were awarded as restricted stock units under CVS’s 2017 Incentive Compensation Plan, with restrictions lapsing in three equal installments beginning March 31, 2027.

When do Prem S. Shah’s new CVS (CVS) stock options vest and expire?

The stock options become exercisable in three equal annual installments starting March 31, 2027. The options have an exercise price of $71.82 per share and expire on March 31, 2036, providing a long-dated incentive tied to CVS Health’s common stock performance over that period.

How are CVS (CVS) restricted stock units for Prem S. Shah scheduled to vest?

The 25,062 restricted stock units awarded to Prem S. Shah under CVS’s 2017 Incentive Compensation Plan vest in three equal installments. The restrictions begin to lapse on March 31, 2027, with one-third of the units releasing each year over a three-year period.

Why did Prem S. Shah surrender CVS (CVS) shares on April 1, 2026?

On April 1, 2026, 1,484 CVS common shares were surrendered at $72.49 per share to pay withholding taxes due upon vesting and settlement of restricted stock units. This tax-withholding disposition satisfies tax obligations without an open-market sale transaction.

How many CVS (CVS) common shares does Prem S. Shah hold after these transactions?

After the reported transactions, Prem S. Shah directly holds 64,356.0985 CVS common shares. This figure reflects his position following the stock option and restricted stock grants, as well as the surrender of 1,484 shares for tax withholding on vested restricted stock units.

What plan governs Prem S. Shah’s CVS (CVS) restricted stock unit award?

Prem S. Shah’s restricted stock unit award was granted under CVS Health’s 2017 Incentive Compensation Plan. The units convert into restricted common stock, with restrictions lapsing in three equal installments starting March 31, 2027, aligning long-term compensation with company performance.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/02/2026 - 04:58 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Shah Prem S

(Last) (First) (Middle)

ONE CVS DRIVE

(Street)

WOONSOCKET RHODE ISLAND 02895

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CVS HEALTH Corp [ CVS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP and Group President

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/31/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock (Restricted)	03/31/2026		A(1)		25,062	A	$71.82	62,852	D
Common Stock	04/01/2026		F(2)		1,484	D	$72.49	64,356.0985	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option(3)	$71.82	03/31/2026		A		161,676		03/31/2027	03/31/2036	Common Stock	161,676	$71.82	161,676	D

Explanation of Responses:

1. Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in three equal installments, commencing 3/31/2027.

2. Surrender of shares in payment of withholding taxes due upon the vesting and settlement of restricted stock units.

3. Option becomes exercisable in three equal annual installments, commencing 3/31/2027.

	/s/ Prem S. Shah	04/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)